Mylan Financial Statements
Mylan Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Mylan Stock Quote & Chart
11/06/09 16:00:02 EST •
NASDAQ •
17.47
•
 +0.0500
•
+0.2870 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Mylan Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 1.08 | 1.15 | 7.01 |
| Price/Earnings Ratio | 28.33 | 23.98 | 25.51 |
| Price/Book Ratio | 1.75 | 1.73 | 6.74 |
| Price/Cash Flow Ratio | 7.83 | 9.29 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Mylan Financial Ratios
Mylan Competitive Intelligence
| Sandoz International GmbH | Teva Pharmaceuticals | Watson Pharmaceuticals | |
|---|---|---|---|
| Annual Sales ($ mil.) | 0.2 | 11,085.0 | 2,535.5 |
| Employees | 150 | 38,307 | 5,070 |
| Market Cap ($ mil.) | -- | 47,077.4 | 3,682.5 |
Competitive Landscape
